Status:
UNKNOWN
Post-operative Imaging in High Grade Glioma: is Management Influenced?
Lead Sponsor:
King's College Hospital NHS Trust
Conditions:
Glioma
Eligibility:
All Genders
18+ years
Brief Summary
Magnetic resonance imaging (MRI) is likely to play an important role in the management of high grade glioma. Appropriate and timely neuroimaging in the follow up period is believed to be crucial in ma...
Eligibility Criteria
Inclusion
- Histologically proven HGG patients (Grade III and IV WHO criteria)
- Underwent surgery, radiotherapy and chemotherapy regimen according to 2018 NICE guidelines (1)
- \>=18 years old
- Has follow-up MRI imaging (T1, T2, FLAIR and T1 with contrast enhancement) and also DSC and DCE imaging
- Evaluated at MDT meetings between March 2018 and March 2020.
Exclusion
- Patients who have insufficient clinical and radiological follow-up
Key Trial Info
Start Date :
July 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 16 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04738110
Start Date
July 20 2020
End Date
December 16 2022
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King´s College Hospital NHS Foundation trust
London, United Kingdom, SE5 9RS